V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006028 | 200014555 | null | null | null | null | 2017-10-19 | null | null | null | CEMIPLIMAB | 101620265 |
| 200006030 | 200014556 | null | 58 | Palliative (P) | null | 2020-03-06 | DABRAFENIB | 02 | N | DABRAFENIB | 100935382 |
| 200006031 | 200014557 | 0 | 0 | Palliative (P) | 2018-12-16 | 2018-12-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101285390 |
| 200006032 | 200014558 | 1.63 | 106.6 | Palliative (P) | 2020-07-18 | 2020-09-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | TRIAL UNSPECIFIED | 100398815 |
| 200006033 | 200014559 | 1.72 | 69.1 | Palliative (P) | 2016-07-21 | 2016-09-05 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100439208 |
| 200006034 | 200014560 | 1.76 | 85 | Palliative (P) | 2016-10-23 | 2016-10-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101631986 |
| 200006035 | 200014561 | 1.88 | null | Palliative (P) | null | 2018-11-24 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100134920 |
| 200006036 | 200014562 | 1.92 | 83.2 | null | 2018-06-03 | 2018-06-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100939961 |
| 200006038 | 200014563 | 1.77 | 95.5 | Palliative (P) | null | 2016-03-27 | Ipilimumab | null | N | IPILIMUMAB | 101357292 |
| 200006040 | 200014565 | null | 95.5 | null | 2021-01-15 | 2021-01-23 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101134011 |
| 200006042 | 200014566 | 1.77 | 90 | Palliative (P) | 2022-05-25 | 2022-05-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101619573 |
| 200006043 | 200014567 | 1.78 | 69.2 | Palliative (P) | 2019-05-14 | 2019-05-14 | DABRAFENIB | 02 | null | DABRAFENIB | 101796630 |
| 200006045 | 200014568 | null | null | null | null | 2020-03-01 | null | null | null | BLEOMYCIN | 101557717 |
| 200006047 | 200014570 | 1.7 | 79.4 | Palliative (P) | 2017-09-25 | 2017-10-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101327005 |
| 200006051 | 200014573 | 1.78 | 83.3 | Palliative (P) | null | 2016-07-26 | null | N | null | IPILIMUMAB + NIVOLUMAB | 100889413 |
| 200006054 | 200014575 | null | 91.6 | Palliative (P) | 2020-02-18 | 2020-02-19 | Trial Unspecified | 02 | N | DABRAFENIB | 101830564 |
| 200006057 | 200014576 | null | 96 | Palliative (P) | null | 2018-08-19 | null | null | null | BLEOMYCIN | 100981911 |
| 200006058 | 200014577 | 1.76 | 60 | null | 2019-10-20 | 2020-04-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100492648 |
| 200006059 | 200014578 | null | 81.4 | Palliative (P) | 2015-11-28 | 2015-11-28 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100453132 |
| 200006061 | 200014579 | null | 64.9 | null | 2021-02-03 | 2021-03-18 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101147958 |
| 200006062 | 200014580 | null | 130 | null | 2021-04-21 | 2021-05-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100003170 |
| 200006063 | 200014581 | null | 73 | Palliative (P) | 2020-03-21 | 2020-04-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101757919 |
| 200006065 | 200014582 | 1.83 | 95.3 | Palliative (P) | 2021-01-04 | 2021-01-11 | DABRAFENIB | 02 | null | DABRAFENIB | 100555312 |
| 200006071 | 200014585 | 1.7 | 91.7 | Palliative (P) | 2019-03-07 | 2019-04-04 | null | 02 | N | DABRAFENIB | 100733178 |
| 200006072 | 200014586 | 1.6 | 111.35 | Palliative (P) | 2020-10-22 | 2020-10-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100660200 |
| 200006074 | 200014587 | 1.78 | null | Adjuvant (A) | 2021-11-30 | 2021-12-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100118142 |
| 200006077 | 200014589 | 1.65 | 118 | Palliative (P) | 2020-12-26 | 2020-12-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101352294 |
| 200006078 | 200014590 | 1.76 | 88 | Palliative (P) | null | 2016-03-19 | Ipilimumab | null | null | IPILIMUMAB | 100970394 |
| 200006083 | 200014595 | null | 82.8 | Palliative (P) | 2019-04-13 | 2019-04-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101212390 |
| 200006085 | 200014597 | 1.65 | 68.7 | Palliative (P) | null | 2021-03-09 | null | null | N | BLEOMYCIN | 100558430 |
| 200006086 | 200014598 | 1.8 | 125.3 | Adjuvant (A) | 2019-07-09 | 2019-07-13 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101351268 |
| 200006089 | 200014600 | null | null | Palliative (P) | 2022-02-11 | 2022-02-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100970159 |
| 200006093 | 200014604 | 1.57 | 93.9 | Palliative (P) | null | 2020-05-01 | null | null | N | CLADRIBINE | 100005705 |
| 200006094 | 200014605 | null | 74 | null | 2020-11-06 | 2021-01-10 | null | N | null | IPILIMUMAB + NIVOLUMAB | 100892637 |
| 200006095 | 200014606 | null | 54 | Palliative (P) | 2016-04-08 | 2017-07-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100473694 |
| 200006096 | 200014607 | null | null | null | null | 2019-01-15 | null | null | null | BINIMETINIB + ENCORAFENIB | 101818474 |
| 200006099 | 200014608 | 1.61 | 68.2 | null | 2022-02-19 | 2022-03-21 | Ipilimumab | 02 | null | IPILIMUMAB | 101845088 |
| 200006100 | 200014609 | 1.77 | 87 | Palliative (P) | 2017-05-25 | 2017-06-09 | CVD (skin) | 02 | null | TRIAL UNSPECIFIED | 101760532 |
| 200006104 | 200014612 | 1.66 | 88.3 | Palliative (P) | 2017-06-24 | 2017-07-03 | Ipilimumab | 02 | N | IPILIMUMAB | 101556373 |
| 200006106 | 200014614 | 1.78 | 83.5 | Palliative (P) | 2021-03-25 | 2021-05-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100732631 |
| 200006107 | 200014615 | 1.5 | 88.5 | Palliative (P) | 2020-09-20 | 2021-10-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100894746 |
| 200006108 | 200014616 | 1.76 | 81 | Palliative (P) | 2015-12-09 | 2018-11-18 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101822703 |
| 200006114 | 200014620 | 1.82 | 90.5 | Palliative (P) | 2020-02-25 | 2020-03-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101596987 |
| 200006118 | 200014622 | 1.74 | 63.5 | 03 | 2021-04-19 | 2021-05-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101416374 |
| 200006120 | 200014624 | 1.61 | 87.4 | Palliative (P) | 2016-03-26 | 2016-03-29 | Ipilimumab | 02 | null | IPILIMUMAB | 101484363 |
| 200006121 | 200014625 | null | 162.9 | Adjuvant (A) | 2017-12-22 | 2018-05-09 | Trial Unspecified | N | N | IPILIMUMAB + NIVOLUMAB | 100641821 |
| 200006122 | 200014626 | 1.85 | 90 | Palliative (P) | 2018-03-07 | 2018-03-12 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100121276 |
| 200006123 | 200014627 | 1.85 | 87 | Palliative (P) | 2018-10-19 | 2018-10-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101416763 |
| 200006124 | 200014628 | null | null | null | null | 2019-04-14 | null | null | null | BLEOMYCIN | 100081113 |
| 200006126 | 200014629 | 1.62 | 91.45 | Palliative (P) | 2018-12-27 | 2019-01-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101413775 |